U.S. Physical Therapy, Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +64.0% | -83.5% | +559.8% | -24.1% | -12.3% | -124.1% | – | -42.8% | +25.0% | -83.9% | +753.7% | – | |
| – | +3.7% | -0.4% | +10.2% | -2.8% | +29.6% | +3.2% | +3.2% | -3.7% | -20.5% | +29.4% | -1.1% | – | |
| – | -4.0% | +11.9% | -3.9% | +0.1% | +3.4% | -10.8% | +19.5% | +6.9% | -6.4% | +9.0% | +137.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -443.9% | – | -54.1% | -284.2% | – | – | -219.6% | – | -1,014.1% | – | – | |
| – | -13.0% | -17.2% | +27.1% | +8.0% | -1.3% | +3.6% | +26.1% | +32.7% | -9.0% | +36.9% | -0.2% | – | |
| – | -50.3% | +143.2% | +39.1% | -79.5% | +1,523.6% | -93.0% | +91.7% | -6.1% | -54.4% | +634.7% | -84.5% | – | |
| – | +0.0% | +2.9% | +100.1% | -50.0% | +0.1% | +2.9% | +100.1% | -50.0% | +0.0% | +2.4% | +98.0% | – | |
| – | +87,396.0% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | +30.7% | -151.1% | -96.3% | – | +1,922.9% | -58.9% | – | |
| – | +6.5% | -66.2% | +347.2% | -39.1% | -98.7% | – | -398.7% | -59.7% | +36.7% | – | -209.2% | – | |
| – | – | -499.5% | – | – | -1,967.5% | – | – | – | – | -259.6% | – | – | |
| – | +78.2% | -89.5% | +939.2% | -26.9% | -13.7% | -142.9% | – | -50.6% | +34.4% | -106.5% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.